REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma Market SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pharma Market SIA Profile Updated: July 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Pharma Market SIA is an enterprise in Latvia, with the main office in Marupe. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on April 18, 2013. 12 (2023) employees currently work for Pharma Market SIA. From the latest financial highlights, Pharma Market SIA reported a net sales revenue increase of 11.32% in 2025. Its’ total assets recorded a growth of 3.73%. Pharma Market SIA’s net profit margin increased by 2.55% in 2025.

Headquarters
Dzirnieku iela 24
Marupe; Marupes municipality; Postal Code: 2167

Contact Details: Purchase the Pharma Market SIA report to view the information.

Basic Information
Total Employees:
Purchase the Pharma Market SIA report to view the information.
Registered Capital:
Purchase the Pharma Market SIA report to view the information.
Financial Auditors:
Purchase the Pharma Market SIA report to view the information.
Incorporation Date:
April 18, 2013
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pharma Market SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
11.32%
Total Operating Revenue
11.4%
Operating Profit
39.67%
Net Profit/Loss for the Period
569.67%
Total Assets
3.73%
Total Equity
44.5%
Operating Profit Margin
0.62%
Net Profit Margin
2.55%
Return on Equity (ROE)
24.15%
Quick Ratio
0.18%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?